Tolerable and Effective Combination of Full-Dose Crizotinib and Osimertinib Targeting MET Amplification Sequentially Emerging after T790M Positivity in EGFR-Mutant Non-Small Cell Lung Cancer.
作者信息
York Emily R, Varella-Garcia Marileila, Bang Tami J, Aisner Dara L, Camidge D Ross
机构信息
Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado.
Department of Radiology, University of Colorado School of Medicine, Aurora, Colorado.
出版信息
J Thorac Oncol. 2017 Jul;12(7):e85-e88. doi: 10.1016/j.jtho.2017.02.020. Epub 2017 Mar 6.
PMID:28274743
Abstract
摘要
Zotero 插件